Alison Lapoint, PT in Lodi, NY - Physical Therapist

Alison Lapoint, PT is a Physical Therapist based in Lodi, New York. Alison Lapoint is licensed to practice in New York (license number 033035) and her current practice location is 8600 Townsendville Rd, Lodi, New York. She can be reached at her office (for appointments etc.) via phone at (607) 280-0079.

NPI number for Alison Lapoint is 1407154388 and her current mailing address is 8600 Townsendville Rd, Lodi, New York. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1407154388.

Contact Information

	Alison Lapoint, PT
	8600 Townsendville Rd, Lodi, NY 14860-9742
	(607) 280-0079
	Not Available

Healthcare Provider's Profile

Full Name	Alison Lapoint
Gender	Female
Speciality	Physical Therapist
Location	8600 Townsendville Rd, Lodi, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1407154388
Provider Enumeration Date: 03/02/2011
Last Update Date: 03/02/2011

Medical Identifiers

Medical identifiers for Alison Lapoint such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1407154388	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	033035 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alison Lapoint is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Alison Lapoint, PT 8600 Townsendville Rd, Lodi, NY 14860-9742 Ph: (607) 280-0079	Alison Lapoint, PT 8600 Townsendville Rd, Lodi, NY 14860-9742 Ph: (607) 280-0079

News Archive

Daiichi buys Japanese rights to CTL's innovative cardiac regeneration medicine, Heartcel

Cell Therapy Ltd. today announced the granting of the Japan license for its innovative cardiac regeneration medicine, Heartcel™ (immuno-modulatory progenitor [iMP] cells) to Daiichi Sankyo.

New study reveals twist in how intoxication happens

As New Year's Eve approaches, many people will experience the familiar buzz that comes from imbibing a favorite cocktail or glass of wine.

French may be headed for similar obesity and heart problems as U.S.

Just 2 pounds of weight gain can greatly increase a person's risk for the metabolic syndrome, a dangerous condition that can lead to type 2 diabetes and coronary heart disease, finds a Kaiser Permanente study.

Who qualifies for a covid booster? The list is growing longer

On Friday, Centers for Disease Control and Prevention Director Rochelle Walensky said people whose jobs put them at risk of coronavirus infection qualify for a shot to boost the protection of their covid-19 vaccination.

Continued HIV/AIDS progress could lead to increased life expectancy, population among developing countries, U.N. report says

Life expectancy in developing countries could increase to 69 years by 2050 if the global health community sustains progress in controlling HIV/AIDS and other infectious diseases, according to a report released Wednesday by the United Nations Population Division, Montreal's Gazette reports (Edwards, Gazette, 3/12).

Alison Lapoint, PT - Physical Therapist in Lodi, NY